Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max S Topp

Showing results (11-20 of 122) with videos related to

Pageof 13
Sort By:
British Journal of Haematology|October 30, 2009
Lenalidomide in patients with refractory or multiple relapsed Hodgkin lymphomaBoris Böll, Peter Borchmann, Max S Topp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 20, 2007
Human CD4+ T cells displaying viral epitopes elicit a functional virus-specific memory CD8+ T cell responseEleni Adamopoulou, Jan Diekmann, Eva Tolosa, et al.
International Journal of Molecular Sciences|June 2, 2021
Two Cases of Pancytopenia with Coombs-Negative Hemolytic Anemia after Chimeric Antigen Receptor T-Cell TherapyDominik Kiem, Michael Leisch, Daniel Neureiter, et al.
The Journal of Experimental Medicine|September 10, 2003
Restoration of CD28 expression in CD28- CD8+ memory effector T cells reconstitutes antigen-induced IL-2 productionMax S Topp, Stanley R Riddell, Yoshiki Akatsuka, et al.
Blood|June 7, 2011
Generation of a multipathogen-specific T-cell product for adoptive immunotherapy based on activation-dependent expression of CD154Nina Khanna, Claudia Stuehler, Barbara Conrad, et al.
The Journal of General Virology|February 17, 2009
Genetically engineered attenuated measles virus specifically infects and kills primary multiple myeloma cellsHorst-Dieter Hummel, Gabriele Kuntz, Stephen J Russell, et al.
Annals of Hematology|September 22, 2018
Neurologic adverse events in patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab: management and mitigating factorsAnthony S Stein, Gary Schiller, Ramsis Benjamin, et al.
Immunity, Inflammation and Disease|December 17, 2016
Hsp90 inhibition ameliorates CD4<sup>+</sup> T cell-mediated acute Graft versus Host disease in miceCarsten Berges, Thomas Kerkau, Sandra Werner, et al.
Blood|December 13, 2003
Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplantsGeorg Rauser, Hermann Einsele, Christian Sinzger, et al.
Leukemia & Lymphoma|November 6, 2009
Clofarabine-based salvage chemotherapy for relapsed or refractory acute leukemia before allogeneic stem cell transplantation: results from a case seriesGötz Ulrich Grigoleit, Markus Kapp, Sen Mui Tan, et al.
Pageof 13

Showing results (11-20 of 122) with videos related to

Sort By:
Pageof 13
British Journal of Haematology|October 30, 2009
Lenalidomide in patients with refractory or multiple relapsed Hodgkin lymphomaBoris Böll, Peter Borchmann, Max S Topp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 20, 2007
Human CD4+ T cells displaying viral epitopes elicit a functional virus-specific memory CD8+ T cell responseEleni Adamopoulou, Jan Diekmann, Eva Tolosa, et al.
International Journal of Molecular Sciences|June 2, 2021
Two Cases of Pancytopenia with Coombs-Negative Hemolytic Anemia after Chimeric Antigen Receptor T-Cell TherapyDominik Kiem, Michael Leisch, Daniel Neureiter, et al.
The Journal of Experimental Medicine|September 10, 2003
Restoration of CD28 expression in CD28- CD8+ memory effector T cells reconstitutes antigen-induced IL-2 productionMax S Topp, Stanley R Riddell, Yoshiki Akatsuka, et al.
Blood|June 7, 2011
Generation of a multipathogen-specific T-cell product for adoptive immunotherapy based on activation-dependent expression of CD154Nina Khanna, Claudia Stuehler, Barbara Conrad, et al.
The Journal of General Virology|February 17, 2009
Genetically engineered attenuated measles virus specifically infects and kills primary multiple myeloma cellsHorst-Dieter Hummel, Gabriele Kuntz, Stephen J Russell, et al.
Annals of Hematology|September 22, 2018
Neurologic adverse events in patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab: management and mitigating factorsAnthony S Stein, Gary Schiller, Ramsis Benjamin, et al.
Immunity, Inflammation and Disease|December 17, 2016
Hsp90 inhibition ameliorates CD4<sup>+</sup> T cell-mediated acute Graft versus Host disease in miceCarsten Berges, Thomas Kerkau, Sandra Werner, et al.
Blood|December 13, 2003
Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplantsGeorg Rauser, Hermann Einsele, Christian Sinzger, et al.
Leukemia & Lymphoma|November 6, 2009
Clofarabine-based salvage chemotherapy for relapsed or refractory acute leukemia before allogeneic stem cell transplantation: results from a case seriesGötz Ulrich Grigoleit, Markus Kapp, Sen Mui Tan, et al.
Pageof 13